T0	Participants 51 108	rectal cancer patients with high preoperative CEA levels.
T1	Participants 273 287	rectal cancer.
T2	Participants 296 472	Between 1994 and 2004, we retrospectively reviewed 122 patients with rectal cancer whose serum CEA levels were measured on the preoperative day and postoperative days 7 and 30.
T3	Participants 473 536	Patients with preoperative CEA levels <5.0 ng/ml were excluded.
T4	Participants 601 665	Patients were categorized into three groups based on R(2) values
T5	Participants 792 818	exponential decrease group
T6	Participants 853 886	nearly exponential decrease group
T7	Participants 925 951	randomized clearance group
T8	Participants 1282 1320	patients with stage III rectal cancer.
T9	Participants 1586 1614	patients with rectal cancer.
T10	Participants 1615 1666	Patients with a randomized pattern of CEA clearance